BioCatalyst

INO — INOVIO PHARMACEUTICALS, INC. catalysts

1 verified catalyst event(s) for INOVIO PHARMACEUTICALS, INC. (ticker INO). Each is linked to its official source. Verified as of 2026-09-20.

Next verified catalyst

2026-12-31 — INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (RE · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-31
in 3mo
ESTIMATED
 READOUT
INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemi
Phase 1/2 · Glioblastoma
 INO INOVIO PHARMACEUTICALS, INC. INO-5401, INO-9012, Cemiplimab, Radiatio ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.